Antitrust Antitrust

Impax request for Supreme Court review of FTC's pay-for-delay case over Opana ER denied

By Max Fillion
  • 13 Dec 2021 09:04
  • 13 Dec 2021 09:04
The US Supreme Court today denied Impax Laboratories request to review the US Federal Trade Commission’s suit accusing it of engaging in an illegal reverse payment over the drug Opana ER.

Impax had asked the Supreme Court to review the case in September (see here), arguing that the US Court of Appeals

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News